PT1527781E - Agente antiprurítico - Google Patents

Agente antiprurítico Download PDF

Info

Publication number
PT1527781E
PT1527781E PT03784565T PT03784565T PT1527781E PT 1527781 E PT1527781 E PT 1527781E PT 03784565 T PT03784565 T PT 03784565T PT 03784565 T PT03784565 T PT 03784565T PT 1527781 E PT1527781 E PT 1527781E
Authority
PT
Portugal
Prior art keywords
antipruritic agent
antipruritic
agent
evoked
administering
Prior art date
Application number
PT03784565T
Other languages
English (en)
Inventor
Fumie Sato
Tohru Tanami
Iwao Arai
Norikazu Takano
Makoto Yagi
Original Assignee
Taisho Pharmaceutical Co Ltd
Fumie Sato
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd, Fumie Sato filed Critical Taisho Pharmaceutical Co Ltd
Publication of PT1527781E publication Critical patent/PT1527781E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
PT03784565T 2002-08-09 2003-08-07 Agente antiprurítico PT1527781E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002234011 2002-08-09

Publications (1)

Publication Number Publication Date
PT1527781E true PT1527781E (pt) 2008-08-12

Family

ID=31711882

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03784565T PT1527781E (pt) 2002-08-09 2003-08-07 Agente antiprurítico

Country Status (18)

Country Link
US (1) US7718701B2 (pt)
EP (1) EP1527781B1 (pt)
JP (1) JP3678366B2 (pt)
KR (1) KR100904583B1 (pt)
CN (1) CN100408039C (pt)
AT (1) ATE401895T1 (pt)
AU (1) AU2003254850B2 (pt)
CA (1) CA2465103C (pt)
DE (1) DE60322395D1 (pt)
DK (1) DK1527781T3 (pt)
ES (1) ES2309380T3 (pt)
HK (1) HK1076391A1 (pt)
MX (1) MXPA04004371A (pt)
NO (1) NO20042053L (pt)
PL (1) PL373819A1 (pt)
PT (1) PT1527781E (pt)
TW (1) TW200404053A (pt)
WO (1) WO2004014394A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266880A1 (en) * 2002-02-22 2004-12-30 Fumie Sato Antipruritics
US7763652B2 (en) 2002-07-12 2010-07-27 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives
US7737182B2 (en) * 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
ES2309380T3 (es) 2002-08-09 2008-12-16 Taisho Pharmaceutical Co., Ltd Agente antipruritico.
CN101119730A (zh) * 2005-02-14 2008-02-06 大正制药株式会社 软膏剂
US8431586B2 (en) 2005-10-03 2013-04-30 Nippon Shinyaku Co., Ltd. Quinazoline derivatives and pharmaceutical compositions thereof
WO2008018592A1 (fr) 2006-08-11 2008-02-14 Taisho Pharmaceutical Co., Ltd. Préparation externe comprenant un dérivé de la prostaglandine
WO2009004873A1 (ja) 2007-06-29 2009-01-08 Taisho Pharmaceutical Co., Ltd. プロスタグランジン誘導体含有水性液剤

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3126924A1 (de) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
US4983629A (en) * 1983-07-08 1991-01-08 Schering Aktiengesellschaft 11-haloprostane derivatives, processes for their preparation and their use as medicinal agents
DE3325175A1 (de) 1983-07-08 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen 11-halogen-prostanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3347128A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5891910A (en) * 1987-07-17 1999-04-06 Schering Aktiengesellschaft 9-halogen-(Z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents
ES2054860T5 (es) * 1987-07-17 2003-11-01 Schering Ag Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
US5252602A (en) 1991-10-11 1993-10-12 Rafeul Alam Effects of misoprostol on allergic responses
EP0583482B1 (en) * 1992-02-07 1999-12-29 Kaken Pharmaceutical Co., Ltd. Remedy for wound or hemorrhoid
CA2140853A1 (en) 1992-07-24 1994-02-03 Takehiro Amano Prostaglandin derivatives
AU669226B2 (en) * 1992-10-20 1996-05-30 Fumie Sato Prostaglandine derivative
US6124344A (en) * 1993-12-28 2000-09-26 Allergan Sales, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
JP3579448B2 (ja) * 1993-12-29 2004-10-20 大正製薬株式会社 プロスタグランジン誘導体、その塩およびその使用
JP3573482B2 (ja) 1994-03-07 2004-10-06 大正製薬株式会社 プロスタグランジン誘導体およびその使用
JP3506485B2 (ja) 1994-04-19 2004-03-15 大正製薬株式会社 プロスタグランジン誘導体
US5807892A (en) * 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
WO1996016935A1 (fr) 1994-11-30 1996-06-06 Taisho Pharmaceutical Co., Ltd. Derive de prostaglandines
JPH0971539A (ja) 1995-09-08 1997-03-18 Mochida Pharmaceut Co Ltd 外用鎮痒剤
JPH09169638A (ja) 1995-10-18 1997-06-30 Sekisui Chem Co Ltd 皮膚疾患治療用外用剤
US5599838A (en) * 1996-02-23 1997-02-04 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives
JPH09286775A (ja) 1996-04-24 1997-11-04 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
WO1997045114A1 (en) 1996-05-30 1997-12-04 Lysis Corporation The treatment of vascular disease with prostaglandins via a sustained-release dermal patch
EP0946155B2 (en) 1996-12-23 2009-01-21 S.L.A. Pharma AG Pharmaceutical composition for treating fecal incontinence
NO317155B1 (no) * 1997-02-04 2004-08-30 Ono Pharmaceutical Co <omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater
JPH10316564A (ja) 1997-05-21 1998-12-02 Sekisui Chem Co Ltd 鎮痒鎮痛外用剤
JPH1180031A (ja) 1997-07-14 1999-03-23 Sekisui Chem Co Ltd 外用剤及び経皮又は経粘膜吸収性を増進する方法
JPH11199478A (ja) 1998-01-05 1999-07-27 Hiroshi Nagoshi レチノイド並びにプロスタグランジンｄ▲２▼誘導体の抗炎症薬としての使用
CA2333038C (en) * 1998-05-25 2008-12-02 Taisho Pharmaceutical Co., Ltd. Sleep-inducing preparation
CN1198649C (zh) 1998-06-03 2005-04-27 盐野义制药株式会社 用于治疗瘙痒的含pgd2受体拮抗剂的药物组合物
US6506789B2 (en) * 1998-06-03 2003-01-14 Shionogi & Co., Ltd. Methods for the treatment of itching comprising administering PGD2 receptor antagonist
TWI249520B (en) * 1998-07-15 2006-02-21 Ono Pharmaceutical Co 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
DK1133571T3 (da) 1998-11-23 2006-10-23 Proteome Sciences Inc Fremgangsmåder og sammensætning til smertebehandling
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
JP2000273083A (ja) 1999-03-19 2000-10-03 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
JP2001089443A (ja) 1999-07-19 2001-04-03 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
EP1211242B1 (en) 1999-09-10 2010-01-13 Taisho Pharmaceutical Co., Ltd Prostaglandin derivatives
ATE259795T1 (de) 1999-09-14 2004-03-15 Merck Frosst Canada Inc Carbonsäuren und acylsulfonamide, solche verbindungen enthaltende zubereitungen und behandlungsmethoden
JP2001122786A (ja) 1999-10-20 2001-05-08 Taisho Pharmaceut Co Ltd 睡眠誘発剤
JP2001151749A (ja) 1999-11-24 2001-06-05 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
AU778321B2 (en) * 1999-11-24 2004-11-25 Taisho Pharmaceutical Co., Ltd. Preparation for nasal administration
KR20020067594A (ko) 2000-01-05 2002-08-22 오노 야꾸힝 고교 가부시키가이샤 5-티아-ω-치환 페닐-프로스타글란딘 Ｅ-알콜, 이들의제조 방법 및 이들을 유효 성분으로서 함유하는 약제
JP2001220355A (ja) 2000-02-07 2001-08-14 Teijin Ltd ＰＰＡＲβ／δ及びγリガンドからなる肥満細胞活性化抑制剤
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
JP4929472B2 (ja) * 2000-08-22 2012-05-09 小野薬品工業株式会社 カルボン酸誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
WO2002020462A1 (fr) 2000-09-01 2002-03-14 Ono Pharmaceutical Co., Ltd. Derives d'acide benzoique et medicaments possedant ces derniers comme principe actif
AU2002229611A1 (en) 2000-12-08 2002-06-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells
US20040266880A1 (en) * 2002-02-22 2004-12-30 Fumie Sato Antipruritics
CA2463438A1 (en) * 2002-02-22 2003-08-28 Taisho Pharmaceutical Co., Ltd. Antipruritics
US7737182B2 (en) * 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
ES2309380T3 (es) 2002-08-09 2008-12-16 Taisho Pharmaceutical Co., Ltd Agente antipruritico.

Also Published As

Publication number Publication date
NO20042053L (no) 2004-05-18
EP1527781A1 (en) 2005-05-04
HK1076391A1 (en) 2006-01-20
ATE401895T1 (de) 2008-08-15
US20050009917A1 (en) 2005-01-13
CN100408039C (zh) 2008-08-06
CA2465103A1 (en) 2004-02-19
AU2003254850A1 (en) 2004-02-25
DK1527781T3 (da) 2008-11-17
KR20050026375A (ko) 2005-03-15
ES2309380T3 (es) 2008-12-16
WO2004014394A1 (ja) 2004-02-19
US7718701B2 (en) 2010-05-18
JP3678366B2 (ja) 2005-08-03
KR100904583B1 (ko) 2009-06-25
AU2003254850B2 (en) 2008-05-15
PL373819A1 (en) 2005-09-19
EP1527781B1 (en) 2008-07-23
CN1620297A (zh) 2005-05-25
DE60322395D1 (de) 2008-09-04
EP1527781A4 (en) 2006-12-13
TWI328574B (pt) 2010-08-11
MXPA04004371A (es) 2004-08-13
JPWO2004014394A1 (ja) 2005-12-02
CA2465103C (en) 2011-04-26
TW200404053A (en) 2004-03-16

Similar Documents

Publication Publication Date Title
HK1076391A1 (en) Antipruritic agent
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
MY150740A (en) Low dose methods for treating disorders in which tnf? activity is detrimental
ATE504315T1 (de) Methode für die ausarbeitung von cd10-aktivierten prodrug-verbindungen
GB0318343D0 (en) No title
GB0318438D0 (en) Early entry
RS59404A (en) Method for producing scopine esters
ATE441418T1 (de) Verwendung von treprostinil zur verbesserung der nierenfunktion
NO20054669L (no) Substituerte kinobenzoxazinanaloger
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
BR0214020A (pt) Método para tratar fibrose cìstica
UA87822C2 (ru) Производные нафтилена как ингибиторы цитохрома p450
AP2001002248A0 (en) Method for treating COPD.
AU3321002A (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
AU2003249090A1 (en) Method for reproducing pleuromutilins
NO20053208D0 (no) Metode for reduktiv dehalogenering.
HK1051558A1 (en) Method for the enzymatic resolution of the racemates of aminomethyl-aryl-cyclohexanol derivatives.
AU2003291143A1 (en) Combination of diamide derivatives and immunosuppressive agents for induction of immune tolerance
MXPA04007064A (es) Metodo para la produccion de pseudoisletas.
MX9804048A (es) Ciclopeptolidos.
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
UA49633A (uk) Спосіб лікування діабетичної ретинопатії
WO2003101391A3 (en) Therapeutic methods